quinazolines has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, G; Feng, L; Hu, Y; Wang, Q; Yu, X; Zeng, L; Zhang, L; Zhang, Y; Zhao, M | 1 |
| Furube, E; Hiratsuka, D; Kurganov, E; Miyata, S; Morita, M | 1 |
2 other study(ies) available for quinazolines and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination.
Topics: Animals; Cell Differentiation; Cells, Cultured; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Quinazolines; Rats; Remyelination; Signal Transduction; Time Factors | 2018 |
VEGF- and PDGF-dependent proliferation of oligodendrocyte progenitor cells in the medulla oblongata after LPC-induced focal demyelination.
Topics: Animals; Cell Division; Demyelinating Diseases; Imatinib Mesylate; Lateral Ventricles; Lipopolysaccharides; Male; Medulla Oblongata; Mice; Mice, Inbred C57BL; Myelin Sheath; Neural Stem Cells; Oligodendrocyte Precursor Cells; Platelet-Derived Growth Factor; Quinazolines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Remyelination; Specific Pathogen-Free Organisms; Vascular Endothelial Growth Factor A | 2019 |